Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AKTS
CGEM
Add up to 3 more stocks
AKTS
Aktis Oncology, Inc.
-3.56%
$17.86-0.66Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$953.81M
52W Range
$14.72 - $34.19
CGEM
Cullinan Therapeutics, Inc.
+1.31%
$16.25+0.21Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$998.69M
52W Range
$5.71 - $23.19
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.97 | 3.10 |
| P/S Ratio | 94.81 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 0.0% |
| Operating Margin | -1149.5% | 0.0% |
| Net Margin | -727.0% | 0.0% |
| ROE | -15.1% | -63.6% |
| ROA | -13.1% | -56.3% |
| ROIC | -16.5% | -68.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 16.33 | 8.42 |
| Quick Ratio | 16.33 | 8.42 |
| Debt/Equity | 0.02 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.